KDNY Shares Outstanding History
Below is a table of the KDNY shares outstanding history going back to 10/2/2020:

Date KDNY Shares Outstanding
10/2/202016.21M
11/2/202042.16M
4/5/202142.38M
5/10/202144.62M
8/10/202144.80M
11/4/202145.07M
3/10/202254.95M
5/6/202255.18M
7/31/202262.90M

Also see: KDNY Market Cap History
KDNY YTD Return
KDNY Historical Shares Outstanding:
+109.99% CAGR
KDNY Historical Shares Outstanding: +109.99% CAGR

Mouse over chart for data details
10/2/2020 ...7/31/2022
Chinook Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing precision medicines for kidney diseases. Co.'s pipeline is focused on kidney diseases with clinical pathways. Co.'s lead clinical program is atrasentan, an endothelin A receptor antagonist. Co.'s second product candidate, BION-1301, is an anti-APRIL monoclonal antibody also in development for patients with IgA nephropathy. Co. developing CHK-336 for the treatment of primary hyperoxaluria as well as secondary hyperoxaluria and idiopathic kidney stone formation. Co. is also conducting research programs in several other rare, severe chronic kidney diseases. We show 9 historical shares outstanding datapoints in our coverage of KDNY's shares outstanding history.

Understanding the changing numbers of KDNY shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like KDNY versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching KDNY by allowing them to research KDNY shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree KDNY Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Chinook Therapeutics (KDNY) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

KEQU Shares Outstanding History
KERX Shares Outstanding History
KIDS Shares Outstanding History
KIN Shares Outstanding History
KLDO Shares Outstanding History
KMPH Shares Outstanding History
KND Shares Outstanding History
KNTE Shares Outstanding History
KOD Shares Outstanding History
KOOL Shares Outstanding History
More Healthcare companies »

 

KDNY Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.